{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:30:53Z","timestamp":1793421053795,"version":"4.5.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.canep.2026.103252","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:36:31Z","timestamp":1791894991000},"page":"103252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Is the standardized incidence ratio of second primary cancers robust to index-cancer survival gains? A simulation and SEER-based evaluation"],"prefix":"10.1016","volume":"105","author":[{"given":"Pierre-Etienne","family":"Heudel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canep.2026.103252_bib1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1186\/s12885-016-2876-y","article-title":"Temporal trends in the risk of developing multiple primary cancers: a systematic review","volume":"16","author":"Ye","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.canep.2026.103252_bib2","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1503\/cmaj.110167","article-title":"Associations between first and second primary cancers: a population-based study","volume":"184","author":"Nielsen","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.canep.2026.103252_bib3","series-title":"New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973\u20132000","author":"Curtis","year":"2006"},{"issue":"8","key":"10.1016\/j.canep.2026.103252_bib4","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.3390\/biomedicines10081984","article-title":"Latency trend analysis as a guide to screening malignancy survivors for second primary thyroid cancer","volume":"10","author":"Hussein","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.canep.2026.103252_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/10732748261432266","article-title":"The changing landscape of second primary malignancies in multiple myeloma: a SEER population-based study between two therapeutic eras","volume":"33","author":"Lu","year":"2026","journal-title":"Cancer Control."},{"issue":"1","key":"10.1016\/j.canep.2026.103252_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"},{"issue":"2","key":"10.1016\/j.canep.2026.103252_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/tri.13081","article-title":"An unjustified benefit: immortal time bias in the analysis of time-dependent events","volume":"31","author":"Gleiss","year":"2018","journal-title":"Transpl. Int."},{"issue":"5","key":"10.1016\/j.canep.2026.103252_bib8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/EDE.0b013e31829f65a7","article-title":"Hazard ratio bias in cohort studies","volume":"24","author":"Lin","year":"2013","journal-title":"Epidemiology"},{"issue":"6","key":"10.1016\/j.canep.2026.103252_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10654-025-01245-6","article-title":"Revisiting the hazards of hazard ratios through simulations and case studies","volume":"40","author":"Abrahamowicz","year":"2025","journal-title":"Eur. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.canep.2026.103252_bib10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology","volume":"167","author":"Suissa","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"10","key":"10.1016\/j.canep.2026.103252_bib11","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/aje\/kwad135","article-title":"Immortal time bias with time-varying exposures in environmental epidemiology: a case study in lung cancer survival","volume":"192","author":"Sheridan","year":"2023","journal-title":"Am. J. Epidemiol."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782126002687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782126002687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:57:33Z","timestamp":1793419053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782126002687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":11,"alternative-id":["S1877782126002687"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2026.103252","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the standardized incidence ratio of second primary cancers robust to index-cancer survival gains? A simulation and SEER-based evaluation","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2026.103252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103252"}}